39.80
1.34%
-0.54
アフターアワーズ:
39.80
Xenon Pharmaceuticals Inc (XENE) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.57%
53.70
|
55.68 | 55.62 | 49.05 | 43.33 |
Depreciation and Amortization |
50.92%
0.851
|
1.734 | 0.602 | 0.354 | 0.515 |
Operating Income/Loss |
3.57%
-53.70
|
-55.68 | -55.62 | -49.05 | -43.33 |
Nonoperating Income/Loss |
23.81%
8.747
|
7.065 | 7.943 | 7.614 | 7.075 |
Income/Loss From Continuing Operations Before Tax |
7.55%
-44.95
|
-48.62 | -47.68 | -41.44 | -36.26 |
Income Tax Expense/Benefit, Deferred |
28.21%
-0.20
|
-0.156 | -0.224 | 0.288 | 0.005 |
Income Tax Expense/Benefit |
30.57%
-0.205
|
-0.157 | -0.22 | 0.29 | 1.139 |
Income/Loss From Continuing Operations After Tax |
7.67%
-44.74
|
-48.46 | -47.46 | -41.73 | -37.40 |
Net Income/Loss
|
7.67%
-44.74
|
-48.46 | -47.46 | -41.73 | -37.40 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | -0.017 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.44%
1.0263
|
66.00 | 65.86 | 65.72 | 1.7052 |
Diluted Average Shares |
98.44%
1.0263
|
66.00 | 65.86 | 65.72 | 1.7052 |
Basic Earnings Per Share |
12.33%
-0.64
|
-0.73 | -0.72 | -0.63 | -0.57 |
Diluted Earnings Per Share |
12.33%
-0.64
|
-0.73 | -0.72 | -0.63 | -0.57 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | -0.017 |
大文字化:
|
ボリューム (24 時間):